Dr. Gregory D. Crenshaw, MD

Dr. Crenshaw practices at Endovascular Health Services Of New Orleans in Metairie, Louisiana.

Dr. Crenshaw's NPI, 1326238171, was assigned on July 27, 2007. Dr. Crenshaw graduated from University of Mississippi School of Medicine in 2001. Dr. Crenshaw holds Louisiana license MD200466.

Dr. Crenshaw's primary practice is Endovascular Health Services of New Orleans, at 1 Galleria Blvd, Metairie, LA 70001-2082. The practice phone is (504) 708-4400.

Dr. Crenshaw's primary practice is Endovascular Health Services Of New Orleans in Metairie, Louisiana. Dr. Crenshaw is also affiliated with East Jefferson General Hospital. The medical group on file is EndoVascular Health Services. Dmand AI also links Dr. Crenshaw to 1 more hospital, 3 medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Crenshaw practices, 5 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Crenshaw's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dmand AI has Dr. Crenshaw's licenses on file in 2 states: Louisiana and Mississippi.

CMS data shows 511 Medicare services from Dr. Crenshaw across 14 procedure codes in 2024, for 211 Medicare patients. Medicare paid $143,525 for them. Every service was in an office.

CMS counts 211 Medicare patients who saw Dr. Crenshaw in 2024. The largest group is under 65, with 75 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 50% are also on Medicaid. Their average risk score is 5.26, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Crenshaw's median patient age at 68, with 51% women.

In 2024, Dr. Crenshaw wrote 113 Medicare Part D claims for 67 patients. 88% of them were for generic drugs. CMS names the drug for 95 of them, across 3 drugs with 11 or more claims each, at $7,577 in total drug cost. In 2023, CMS named 107 claims across 3 drugs.

Dr. Crenshaw accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Crenshaw, published from 2010 to 2012. The most frequent topics are Angioplasty, Carotid Artery Diseases and Cost-Benefit Analysis. Dr. Crenshaw's most frequent co-authors are Hernan Antonio Bazan, MD, Waldemar C. Sternbergh, MD and John S. Bolton, MD.

CMS Open Payments shows 258 general payments to Dr. Crenshaw from 31 drug and device companies from 2016 to 2025. Device or supply loans make up the largest share, 75% of the total. AngioDynamics, Inc. paid the most, $44,106.

Dr. Crenshaw graduated from University of Mississippi School of Medicine in 2001.